Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice

Behavioural Pharmacology

Volumn 10, Issue 8, 1999, Pages 731-737

  Baratti, C M ^a   Boccia, M M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Inhibitory avoidance; Long term retention; Memory; Mouse; Nitric oxide; Phosphodiesterase isoenzymes; Sildenafil; Soluble guanylyl cyclase

Indexed keywords

GUANYLATE CYCLASE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN;

EID: 0033372856     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199912000-00004     Document Type: Article

References (30)

1. Ballard SA, Turner LA, Naylor AM (1996). Sildenafil, a potent selective inhibitor of type 5 phosphodiesterase, enhances nitric oxide-dependent relaxation of rabbit corpus cavernosum. Br J Pharmacol 118 (Suppl.): 154P.
2. Baratti CM, Kopf SR (1996). A nitric oxide synthase inhibitor impairs memory storage in mice. Neurobiol Learn Mem 65: 197-201.
3. Beavo J (1996). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748.
4. Boccia MM, Kopf SR, Baratti CM (1999). Phlorizin, a competitive inhibitor of glucose transport, facilitates memory storage in mice. Neurobiol Learn Mem 71:104-112.
5. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ (1996). Sildenafil, a novel effective oral therapy for male erectil dysfunction. Br J Urol 78:257-261.
6. Clark KB, Krahl SE, Smith DC, Jensen RA (1995). Posttraining unilateral vagal stimulation enhance retention performance in the rat. Neurobiol Learn Mem 63:213-216.
7. Duman RS, Nestler EJ (1999). Cyclic nucleotides. In: Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (editors). Philadelphia: Lippincott-Raven, pp. 443-451.
8. FDA (1998). Viagra® tablets (sildenafil citrate). Review and evaluation of pharmacology and toxicology data. Report from the Division of Cardio-renal Drug Products (HFD-10), Center for Drug Evaluation and Research. Washington, DC: Food and Drug Administration.
9. Fin C, Da Cunha C, Bromberg E, Schmitz PK, Bianchin M, Medina JH et al. (1995). Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol Learn Mem 63:113-115.
10. Garthwaite J (1991). Glutamate nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-68.
11. Gold PE (1986). The use of avoidance training in studies of modulation of memory storage. Behav Neural Biol 46:87-98.
12. Gold PE (1989), Neurobiological features common to memory modulation by many treatments. Amin Learn Behav 7:94-100.
13. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1988). Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397-1404.
14. Holscher C, Rose SPR (1992). An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 145:165-167.
15. Izquierdo I (1984). Endogenous state dependency: memory depends on the relation between the neurohumoral and hormonal states present after training and the time of testing. In: Neurobiology of Learning and Memory. Lynch G, McGaugh JI, Weinberger NM (editors). New York: Guilford Press, pp. 333-350.
16. Izquierdo I, Medina JH (1997). The biochemistry of memory formation and its regulation by hormones and neuromodulators, Psychobiology 25:1-9.
17. Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Mimmack M et al. (1997). Formation of olfactory memories mediated by nitric oxide. Nature 388:670-674.
18. Kopf SR, Baratti CM (1996). Memory modulation by posttraining glucose of insulin remains evident at long retention intervals. Neurobiol Learn Mem 65:189-191.
19. Li J, Iadecola C (1994). Nitric oxide and adenosine mediate vasodilatation during functional activation in cerebellar cortex. Neuropharmacology 33:1453-1462.
20. McGaugh JL (1973). Drug facilitation of learning and memory. Annu Rev Pharmacol 13:229-241.
21. McGaugh JL (1989). Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 12:255-287.
22. McGaugh JL (1992). Neuromodulatory systems and the regulation of memory storage. In: Neuropsychology of Memory. Squire LR, Butters N (editors). New York: Guilford Press, pp. 386-401.
23. Moncada S, Palmer RMJ, Higgs EA (1991). Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
24. Nathan C (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064.
25. Nelson RJ, Kriegsfeld LJ, Dawson VL, Dawson TM (1997). Effects of nitric oxide on neuroendocrine function and behavior. Front Neuroendocrinol 18:463-491.
26. Packard MG, Williams CL, Cahill L, McGaugh JL (1995). The anatomy of memory modulatory system: From periphery to brain. In: Neurobehavioral Plasticity, Learning Development and Response to Brain Insults. Spear NE, Spear LP, Woodrugg ML (editors). New Jersey: Erlbaum, pp. 146-184.
27. Schuman ER, Madison DU (1994). Nitric oxide and synaptic function. Annu Rev Neurosci 17:153-183.
28. Siegel S (1956). Non-parametric Statistics for the Behavioral Sciences. New York: McGraw-Hill.
29. Terrett NK, Bell AS, Brown D, Ellis P (1995). UK-92480, a potent and selective inhibitor of type V(A) cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. In: 210th ACS National Meeting. Chicago, IL: American Chemical Society, Abstract MEDI 229.
30. Williams CL, Jensen RA (1991). Vagal afferents: A possible mechanisms for the modulation of peripherally acting agents In: Peripheral Signalling of the Brain: Role in Neural-Immune Interactions and Memory. Frederickson RCA, McGaugh JL, Felton DL (editors). Toronto: Hogrefe and Huber, pp. 467-472.